GLENMARK — Glenmark Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹628.43bn
- IN₹620.37bn
- IN₹169.83bn
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter
India's Glenmark Pharma posts higher quarterly profit on strong demand
Brief: Glenmark Pharma Q1 Consol Net Profit 4.83 Billion Rupees
Brief: Glenmark Pharmaceuticals Inc., USA Launches Sugammadex Injection, 200 Mg/2 Ml & 500 Mg/5 Ml Single-Dose Vials
India's pharma stocks fall after Trump outlines steep tariffs on generic drug imports
India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports
Brief: Glenmark Pharma Receives FDA Approval To Expand Ryaltris Use For Children Aged 6 To Under 12
India's Glenmark Pharma falls after agreeing to $29.6 million settlement in US
India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law
India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law
Brief: Glenmark Pharma Says Unit Launches Olanzapine For Injection, 10 Mg/Vial, Single-Dose Vial
Brief: Glenmark Pharma Says Unit Advances Multi-Country Phase 3 Trial For Trastuzumab Rezetecan In Platinum-Resistant Ovarian Cancer
Brief: Glenmark Pharma Says Glenmark Pharmaceuticals Inc Usa Launches Methylene Blue Injection Usp, 50 Mg/10 Ml Single-Dose Vial
Brief: Glenmark Pharma Launches Winlevi 10 Mg/G Cream In Key European Markets
Brief: Glenmark Pharma Says Glenmark Pharmaceuticals USA Launches Lacosamide Injection USP
Brief: Glenmark Pharma Approves Transfer Of Nebulizer Brands/Ip Portfolio To Unit